Alerts will be sent to your verified email
Verify EmailAAREYDRUGS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Aarey Drugs & Pharmaceuticals Ltd. specializes in manufacturing drugs and intermediates like metronidazole and nitro imidazole. Their product focus areas include Allergy, Dermatology, and Infectious Diseases.
Aarey Drugs & Pharma major competitors are Oxygenta Pharma, Natural Capsules, Ambalal Sarabhai Ent, Sat Kartar Shopping, Brooks Laboratories, Syschem (India), IndoAmerican Advance.
Market Cap of Aarey Drugs & Pharma is ₹197 Crs.
While the median market cap of its peers are ₹210 Crs.
Aarey Drugs & Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.